MedTrace Logo

Strengthening in Sub-acute Stroke Survivors: A Randomized Controlled Trial

NCT06140381 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-20

No results posted yet for this study

Summary

The goal of this study is to compare between Eccentric training and conventional therapy in sub-acute stroke survivors. The primary objective of this study is to evaluate improvements in gait speed after four months of ET in comparison to conventional therapy for patients with sub-acute stroke. Secondary objectives involve assessing: i) modifications in neuromuscular parameters of PF, ii) changes in muscle stiffness within PF during passive mobilization and active force generation, and iii) modifications in architectural parameters of PF.

Conditions

  • Hemiparesis;Poststroke/CVA

Interventions

PROCEDURE

Eccentric training

The eccentric program will last for 16 weeks, with a frequency of 2 sessions per week, totalling 32 sessions. At least 1 day of rest will be required between two training sessions. The participants will be placed in the similar position of the neuromuscular assessments (reference position). The Biodex System 4 dynamometer settings for the exercise sessions were also like the settings used for the assessments. The training program will be divided into two phases: a familiarization phase and a progression phase

PROCEDURE

Conventional therapy

3 sessions per week of physical therapy with musculotendinous stretching and balance rehabilitation

Sponsors & Collaborators

  • Henri Mondor University Hospital

    collaborator OTHER

  • Clinique Du Parc de Belleville

    lead OTHER

Principal Investigators

  • Fedele Jean Michel, Investigator · Clinique Du Parc de Belleville

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-06-01
Completion
2024-10-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06140381 on ClinicalTrials.gov